Stegent Equity Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249K Hold
979
0.18% 99
2026
Q1
$239K Buy
+979
New +$228K 0.2% 96
2023
Q3
Sell
-1,324
Closed -$219K 61
2023
Q2
$219K Hold
1,324
0.25% 60
2023
Q1
$205K Sell
1,324
-199
-13% -$32.1K 0.2% 64
2022
Q4
$269K Hold
1,523
0.32% 56
2022
Q3
$249K Hold
1,523
0.37% 53
2022
Q2
$269K Sell
1,523
-273
-15% -$48.6K 0.35% 60
2022
Q1
$318K Sell
1,796
-202
-10% -$34.4K 0.27% 76
2021
Q4
$342K Buy
+1,998
New +$327K 0.28% 82

Other funds holding JNJ

Stegent Equity Advisors's JNJ Position: Q2 2026 in Review

Stegent Equity Advisors held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 979 shares worth $249K. The position accounts for 0.18% of the portfolio, ranked #99.

Stegent Equity Advisors first reported a position in JNJ in Q4 2021 and has held it in 9 quarters since. The position peaked at $342K in Q4 2021. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Stegent Equity Advisors held 979 shares of Johnson & Johnson worth $249K as of Q2 2026.
  • Stegent Equity Advisors left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.18% of Stegent Equity Advisors's portfolio in Q2 2026, its #99 holding.
  • Stegent Equity Advisors first reported a position in Johnson & Johnson in Q4 2021 and has held it in 9 quarters since.
  • Stegent Equity Advisors's Johnson & Johnson position peaked at $342K in Q4 2021.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Stegent Equity Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.